Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study

Table 4 Characteristics of individuals co-infected with HIV and invasive meningococcal disease (IMD) in England during 2011–2013

Age group at IMD (years)	Group	Time between HIV and IMD diagnosis	Time between ART and IMD	CD4 <350 cells/mm³ at HIV diagnosis	CD4 at IMD <350 cells/mm³	HIV risk	Region of birth	Year of arrival	Clinical presentation	ICU admission
<16	B	2 years	2 years	N	N	MTCT	Africa	2008	Septicaemia	N
16–24	W	13 years	-	N/A	N/A	MTCT	Africa	2000	Pneumonia	Y
16–24	B	After IMD	After IMD	Y	N/A	MSM	Asia	2008	Men & Sep	Y
16–24	Y	2 years	2 years	Y	N	HET	Africa	2004	Men & Sep	Y
25–44	Y	11 years	11 years	Y	Y	HET	Africa	2002	Septic arthritis	N
25–44	C	9 years	9 years	N	N	HET	Africa	2000	Septicaemia	N
25–44	W	8 years	8 years	N	N	HET	Africa	2004	Septicaemia	Y
25–44	B	5 years	4 years	Y	Y	HET	Africa	2004	Septicaemia	N
45–64	C	5 years	At time of IMD	N	N/A	MSM	UK	-	Septicaemia	N
45–64	Y	16 years	2 years	N	Y	HET	UK	-	Pneumonia	N
45–64	Y	10 years	At time of IMD	Y	N/A	HET	Africa	1988	Septicaemia	Y
45–64	B	3 years	3 years	Y	Y	HET	Africa	2002	Meningitis	N
45–64	Y	At the time of IMD	After IMD	N	N	HET	Africa	1975	Men & Sep	Y
45–64	C	At the time of IMD	Not on ART	Y	Y	HET	UK	-	Septicaemia	N

HET heterosexual contact, ICU intensive care unit, Men & Sep meningitis and septicaemia, MSM men who have sex with men, MTCT mother-to-child transmission, N no, N/A not available, Y yes

ISSN: 1741-7015